Symbol="ADPT"
AssetType="Common Stock"
Name="Adaptive Biotechnologies Corp"
Description="Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington."
CIK="1478320"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1128512000"
EBITDA="-171424992"
PERatio="None"
PEGRatio="0"
BookValue="2.939"
DividendPerShare="0"
DividendYield="0"
EPS="-1.38"
RevenuePerShareTTM="1.289"
ProfitMargin="-1.059"
OperatingMarginTTM="-1.045"
ReturnOnAssetsTTM="-0.146"
ReturnOnEquityTTM="-0.4"
RevenueTTM="184335000"
GrossProfitTTM="-13657000"
DilutedEPSTTM="-1.38"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.025"
AnalystTargetPrice="12.29"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="6.64"
PriceToBookRatio="2.436"
EVToRevenue="4.698"
EVToEBITDA="-3.906"
Beta="1.141"
num_52WeekHigh="13.21"
num_52WeekLow="5.96"
num_50DayMovingAverage="7.12"
num_200DayMovingAverage="7.94"
SharesOutstanding="144311000"
DividendDate="None"
ExDividendDate="None"
symbol="ADPT"
open="7.78"
high="8.12"
low="7.48"
price="8.08"
volume="961255.00"
latest_trading_day="2023-07-21"
previous_close="7.70"
change="0.38"
change_percent="4.9351%"
aroon_positive_momentum_days="52"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="955828"
Change_recent_avg="-0.01"
Delta_recent_avg="0.47"
Variance_recent_avg="0.24"
Change_ratio_recent_avg="-0.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="1137"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0170.jpeg"
image_negative_thumbnail_id_2="500"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="524"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_positive_thumbnail_id_1="608"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0100.jpeg"
image_positive_thumbnail_id_2="631"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0077.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
